Mucosal Melanoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-06-26
Clinical Trial Update: Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma [Phase 2]
A Phase 2 neoadjuvant trial of pembrolizumab plus lenvatinib for mucosal melanoma has been withdrawn.